DAFNA Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
135,271
-106,729
| -44% | -$1.08M | 0.38% | 48 |
|
|
2025
Q1 | $1.35M | Buy |
+242,000
| New | +$1.35M | 0.38% | 46 |
|
|
2024
Q3 | – | Sell |
-36,000
| Closed | -$255K | – | 85 |
|
|
2024
Q2 | $255K | Buy |
+36,000
| New | +$255K | 0.06% | 77 |
|
|
2024
Q1 | – | Sell |
-72,797
| Closed | -$670K | – | 79 |
|
|
2023
Q4 | $670K | Buy |
+72,797
| New | +$670K | 0.16% | 62 |
|
|
2023
Q2 | – | Sell |
-170,326
| Closed | -$971K | – | 77 |
|
|
2023
Q1 | $971K | Sell |
170,326
-93,911
| -36% | -$535K | 0.29% | 46 |
|
|
2022
Q4 | $1.56M | Sell |
264,237
-149,289
| -36% | -$879K | 0.44% | 50 |
|
|
2022
Q3 | $1.32M | Sell |
413,526
-2,400
| -0.6% | -$7.68K | 0.36% | 51 |
|
|
2022
Q2 | $1.86M | Buy |
+415,926
| New | +$1.86M | 0.51% | 48 |
|